{"id":"W2416661311","doi":"10.1177/135965350501000119","title":"Challenges for the Clinical Development of New Nucleoside Reverse Transcriptase Inhibitors for HIV Infection","year":2005,"lang":"en","type":"article","venue":"Antiviral Therapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; McGill University; Jewish General Hospital","funders":"","keywords":"Tolerability; Clinical trial; Drug resistance; Nucleoside Reverse Transcriptase Inhibitor; Reverse transcriptase; Drug development; Clinical study design; Medicine; Pharmacodynamics; Pharmacology; Reverse-transcriptase inhibitor; Intensive care medicine; Biology; Drug; Human immunodeficiency virus (HIV); Bioinformatics; Pharmacokinetics; Virology; Antiretroviral therapy; Viral load; Adverse effect; Genetics; RNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.118861,0.001301589,0.002505677,0.001410858,0.001676605,0.01013449,0.004785349,0.008592373,0.01977813],"category_scores_gemma":[0.08858339,0.001134261,0.002451615,0.0009297245,0.006315678,0.008957863,0.005452056,0.01541926,0.01087226],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003992102,"about_ca_system_score_gemma":0.01706069,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002285164,"about_ca_topic_score_gemma":0.00282142,"domain_scores_codex":[0.9696078,0.01418973,0.003101681,0.001887957,0.009756805,0.001456133],"domain_scores_gemma":[0.9152505,0.03621115,0.004997172,0.004269022,0.0252619,0.01401014],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001396043,0.001517433,0.001938409,0.003242952,0.0001984866,0.0007023444,0.0008468337,0.003797051,0.008823267,0.05146564,0.216408,0.7096636],"study_design_scores_gemma":[0.0009419415,0.005154604,0.002372562,0.002811853,0.0001114711,0.00146848,0.0008839836,0.002274596,0.001853341,0.03250896,0.949487,0.0001311352],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"review","genre_scores_codex":[0.00968625,0.2790108,0.0339271,0.6305742,0.01333719,0.001541677,0.0007113911,0.0008486253,0.03036272],"genre_scores_gemma":[0.1201109,0.4186266,0.1968499,0.2047596,0.03321825,0.004565899,0.002858119,0.0008111917,0.0181996],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.118861,"threshold_uncertainty_score":0.6286048,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1290066153084961,"score_gpt":0.3734704503012295,"score_spread":0.2444638349927334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}